Detalles de la búsqueda
1.
Direct-acting antivirals in women of reproductive age infected with hepatitis C virus.
J Viral Hepat
; 31(6): 309-319, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38483035
2.
Real-world effectiveness and safety of direct-acting antivirals in patients with cirrhosis and history of hepatic decompensation: Epi-Ter2 Study.
Liver Int
; 41(8): 1789-1801, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33655628
3.
Is an 8-week regimen of glecaprevir/pibrentasvir sufficient for all hepatitis C virus infected patients in the real-world experience?
J Gastroenterol Hepatol
; 36(7): 1944-1952, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33171526
4.
Real-world experience with Grazoprevir/Elbasvir in the treatment of previously "difficult to treat" patients infected with hepatitis C virus genotype 1 and 4.
J Gastroenterol Hepatol
; 35(7): 1238-1246, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31734959
5.
The efficacy of paritaprevir/ritonavir/ombitasvir+dasabuvir and ledipasvir/sofosbuvir is comparable in patients who failed interferon-based treatment with first generation protease inhibitors - a multicenter cohort study.
BMC Infect Dis
; 18(1): 580, 2018 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-30445916
6.
Treatment of the most difficult-to-cure hepatitis C virus-infected population with sofosbuvir / velpatasvir.
Pol Arch Intern Med
; 134(2)2024 02 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38164647
7.
Effectiveness and safety of direct-acting antivirals in the therapy of HCV-infected elderly people.
Minerva Med
; 2024 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38591836
8.
Real-life effectiveness of antiviral therapy for HCV infection with pangenotypic regimens in HIV coinfected patients.
Expert Rev Anti Infect Ther
; : 1-6, 2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38722307
9.
Controlled Attenuation Parameter Is Associated with a Distinct Systemic Inflammatory Milieu after Clearance of HCV Infection.
Biomedicines
; 11(6)2023 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37371624
10.
Real-World Effectiveness and Safety of Direct-Acting Antivirals in Patients with Chronic Hepatitis C and Epilepsy: An Epi-Ter-2 Study in Poland.
J Pers Med
; 13(7)2023 Jul 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37511724
11.
Changes in characteristics of patients with hepatitis C virus-related cirrhosis from the beginning of the interferon-free era.
World J Gastroenterol
; 29(13): 2015-2033, 2023 Apr 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37155527
12.
Pangenotypic triple versus double therapy in HCV-infected patients after prior failure of direct-acting antivirals.
Clin Exp Hepatol
; 9(3): 193-201, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37790681
13.
Real-world effectiveness and safety of direct-acting antivirals in hepatitis C virus patients with mental disorders.
World J Gastroenterol
; 29(25): 4085-4098, 2023 Jul 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37476581
14.
Real-world effectiveness of genotype-specific and pangenotypic direct-acting antivirals in HCV-infected patients with renal failure.
Clin Exp Hepatol
; 9(4): 320-334, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38774196
15.
Best therapy for the easiest to treat hepatitis C virus genotype 1b-infected patients.
World J Gastroenterol
; 28(45): 6380-6396, 2022 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36533109
16.
Inflammatory and thrombotic parameters associated with the COVID-19 course in Poland (SARSTer study).
Adv Med Sci
; 67(2): 291-297, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35932632
17.
Efficacy of 8- versus 12-week treatment with ledipasvir/sofosbuvir in chronic hepatitis C patients eligible for 8-week regimen in a real-world setting.
Arch Med Sci
; 18(6): 1460-1466, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36457986
18.
HCV Genotype Has No Influence on the Incidence of Diabetes-EpiTer Multicentre Study.
J Clin Med
; 11(2)2022 Jan 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35054072
19.
Hepatitis C Infection as a Risk Factor for Hypertension and Cardiovascular Diseases: An EpiTer Multicenter Study.
J Clin Med
; 11(17)2022 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36079122
20.
Effectiveness of Tocilizumab with and without Dexamethasone in Patients with Severe COVID-19: A Retrospective Study.
J Inflamm Res
; 14: 3359-3366, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34295173